LICENSES ACQUIRED (Details) $ in Thousands |
3 Months Ended | |||
|---|---|---|---|---|
|
Nov. 16, 2021
shares
|
Jun. 29, 2021
USD ($)
|
Mar. 31, 2022
USD ($)
item
|
Dec. 31, 2021
USD ($)
|
|
| Licenses acquired | ||||
| Second installment payable | $ 6,285 | $ 8,137 | ||
| D F D Agreement | ||||
| Licenses acquired | ||||
| Amount payable | $ 10,000 | |||
| Amount payable to fund clinical trials | $ 24,000 | |||
| D F D Agreement | Contingent Payment Derivative | ||||
| Licenses acquired | ||||
| Unregistered shares issued | shares | 545,131 | |||
| Number of payments | item | 1 | |||
| D F D Agreement | Minimum | ||||
| Licenses acquired | ||||
| Percentage of royalties payable on net sales | 10.00% | |||
| D F D Agreement | Maximum | ||||
| Licenses acquired | ||||
| Threshold additional contingent regulatory and commercial milestone payments payable | $ 163,000 | |||
| Percentage of royalties payable on net sales | 20.00% |
| X | ||||||||||
- Definition Amount payable to fund the clinical trials under the license, collaboration, and assignment agreement. No definition available.
|
| X | ||||||||||
- Definition Number of payments to be made on contingent consideration in license, collaboration and assignment agreement. No definition available.
|
| X | ||||||||||
- Definition The percentage of royalties payable on net sales under the license, collaboration, and assignment agreement. No definition available.
|
| X | ||||||||||
- Definition Second installment payable under the license, collaboration, and assignment agreement. No definition available.
|
| X | ||||||||||
- Definition Threshold additional contingent regulatory and commercial milestone payments payable under the license, collaboration, and assignment agreement. No definition available.
|
| X | ||||||||||
- Definition Total amount payable under the license, collaboration, and assignment agreement. No definition available.
|
| X | ||||||||||
- Definition Total number of unregistered common shares of an entity that have been sold or granted to shareholders. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|